Nebenwirkungen · Gilenya
Gilenya 0.25 mg hard capsules Gilenya 0.5 mg hard capsules · Abschnitt 4.8 · PDF-Seite 15
HOS-124792 · Präparat HOS-095937
Adverse reactions reported in clinical trials and derived from post-marketing experience via spontaneous case reports or literature cases are shown below. Frequencies were defined using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1 000 to <1/100); rare (≥1/10 000 to <1/1 000); very rare (<1/10 000); not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in the order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-29T11:20:00Z · SHA-256 14535f3eca03884aa2cdac6745c9ca3473c671171833be03bbc450e2d1533438 · Passage 742174fef6412966e8d95388cfe1d2070fe5ea8106b1f6028dc3278cdc81b4fb · Zeichen 350–853 im Abschnitt